Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 126 Reports

🤖 AI Analyzed

Recent

📄 Page 10 of 11

ALLEGRO MICROSYSTEMS, INC.

10-K May 21, 2026

Key Highlights

Sales jumped 22.8% to $890.1 million, driven by strong demand in EV and AI data ...
Achieved a core profit turnaround of $18.5 million, representing a massive $38.3...
Operating cash flow surged 163.5% to $163.1 million, demonstrating strong cash-g...

Read Analysis

🤖 AI Generated

V F CORP

10-K May 20, 2026

Key Highlights

Successfully divested Dickies for $600.5 million in cash, generating a $127.2 mi...
Reduced long-term debt by $2.2 billion over two years, improving balance sheet h...
Secured a $149.7 million tariff refund plus interest following a U.S. Supreme Co...

Read Analysis

🤖 AI Generated

EnerSys

10-K May 20, 2026

Key Highlights

Sales rose 3.7% to $3.75 billion, driven by a 7.8% boom in AI-related data cente...
Operating cash flow doubled to $547.6 million, enabling $370.7 million in share ...
Acquired Bren-Tronics for $206.4 million in cash to expand high-margin military ...

Read Analysis

🤖 AI Generated

Alibaba Group Holding Ltd

20-F May 20, 2026

Key Highlights

Cloud sales to outside customers jumped 40% last quarter, with AI products contr...
Maintains massive cash reserves of $41.6 billion in the bank and generated $11 b...
Strategic pivot to high-growth areas including AI, cloud computing, and fast del...

Read Analysis

🤖 AI Generated

Roivant Sciences Ltd.

10-K May 20, 2026

Key Highlights

Massive cash fortress of $4.3 billion in cash and short-term investments to fund...
Genevant (83% owned) secured a $2.25 billion patent settlement from Moderna, wit...
Highly anticipated late 2026 catalysts, including an FDA approval decision for B...

Read Analysis

🤖 AI Generated

Immunovant, Inc.

10-K May 20, 2026

Key Highlights

IMVT-1402 targets a massive market of over 4 million patients with rare, IgG-med...
Strong patent protection for IMVT-1402 extends until at least 2043, with potenti...
A robust cash pile of $902.1 million provides a runway of approximately 2.2 year...

Read Analysis

🤖 AI Generated

Dynatrace, Inc.

10-K May 20, 2026

Key Highlights

Crossed the $2 billion sales milestone, representing 19% year-over-year growth.
Maintained a fortress balance sheet with $1.227 billion in cash and virtually ze...
Demonstrated strong customer loyalty with a 110% net retention rate and 18% ARR ...

Read Analysis

🤖 AI Generated

HAEMONETICS CORP

10-K May 20, 2026

Key Highlights

Gross margin improved significantly from 55% to 59%, indicating stronger core pr...
The Hospital segment continues to be the fastest-growing business unit, now acco...
Proactive capital allocation was demonstrated through $100 million in stock buyb...

Read Analysis

🤖 AI Generated

FLEX LTD.

10-K May 20, 2026

Key Highlights

Cloud Power Infrastructure (CPI) segment sales skyrocketed 38% due to massive de...
Planned spin-off of the high-growth CPI segment into a separate public company b...
Gross profit jumped 19% to $2.6 billion, expanding gross margin to 9.3% through ...

Read Analysis

🤖 AI Generated

James Hardie Industries plc

10-K May 19, 2026

Key Highlights

Total sales surged 25% to $4.84 billion, driven by the strategic acquisition of ...
The company is successfully executing a 'material conversion' strategy to replac...
Direct-to-consumer marketing bypasses distributors, building strong brand power ...

Read Analysis

🤖 AI Generated

Under Armour, Inc.

10-K May 19, 2026

Key Highlights

Founder Kevin Plank returned as CEO to lead a major restructuring effort expecte...
Successfully remediated past bookkeeping weaknesses and avoided asset write-down...
Proactively set aside $605.4 million in a trust to pay off older debt maturing i...

Read Analysis

🤖 AI Generated

Doximity, Inc.

10-K May 19, 2026

Key Highlights

Active users of workflow tools jumped 30% to 810,000, demonstrating strong daily...
Over 140 top U.S. health systems adopted the new Clinical AI Suite, bolstered by...
Authorized a new $500 million stock buyback program in February 2026, reflecting...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage